Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations
NCT ID: NCT01903148
Last Updated: 2014-01-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
455 participants
OBSERVATIONAL
2011-10-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
OPTIMISE-CKD Study_current Clinical Landscape in Spain
NCT06614712
Impact on Mortality of Screening for Kidney Disease Associated With a Specialized Intervention During Hospitalization in a Territorial Hospital Trust
NCT05033652
Serum Hepcidin, Haemoglobin Level and Iron Status in Chronic Kidney Disease Patients (CKD) With Anaemia
NCT04102319
Early Detection of Chronic Kidney Disease
NCT06950151
Emergency Department Management of Patients With Renal Infarction
NCT06515379
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients starting anemia treatment (naïve) after six months of the last recommendations of the European Anemia Working Group ERBP (January 2011).
* Patients in treatment who changed from previous ESA treatment since January 2011 (converted patients
Exclusion Criteria
* Kidney transplant patients.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundación Senefro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alberto Martinez Castelao, Doctor
Role: PRINCIPAL_INVESTIGATOR
Hospital Bellvitge
Aleix Cases, Doctor
Role: PRINCIPAL_INVESTIGATOR
Hospital Clinic of Barcelona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Puerto Real
Cadiz, Andalusia, Spain
Hospital de Jerez
Jerez de la Frontera, Andalusia, Spain
Clínico V. Victoria
Málaga, Andalusia, Spain
Hospital Son Llatzer
Palma de Mallorca, Balearic Islands, Spain
Hospital Universitario Nuestra Señora De Candelaria
Santa Cruz de Tenerife, Canary Islands, Spain
Hospital Marques de Valdecilla
Santander, Cantabria, Spain
Hospital Virgen de la Luz
Toledo, Castille-La Mancha, Spain
Fundación Puigvert
Barcelona, Catalonia, Spain
Hospital Bellvige
Barcelona, Catalonia, Spain
Hospital Bellvitge
Barcelona, Catalonia, Spain
Hospital Clinic
Barcelona, Catalonia, Spain
Hospital Germans Trias i Pujol
Barcelona, Catalonia, Spain
Hospital Valld'Hebron
Barcelona, Catalonia, Spain
Sagrat Cor
Barcelona, Catalonia, Spain
Clinica Girona
Girona, Catalonia, Spain
Hospital Josep Trueta
Girona, Catalonia, Spain
Arquitecto Marcide
Ferrol, Galicia, Spain
Complexo Hospitalario de Ourense
Ourense, Galicia, Spain
Complejo Hospitalario Universitario de Santiago
Santiago de Compostela, Galicia, Spain
Hospital 12 de Octubre
Madrid, Madrid, Spain
Hospital Clínico San Carlos
Madrid, Madrid, Spain
Hospital Gregorio Marañón
Madrid, Madrid, Spain
Hospital La Paz
Madrid, Madrid, Spain
Hospital La Princesa
Madrid, Madrid, Spain
Hospital General de Alicante
Alicante, Valencia, Spain
Hospital de Castellón
Castellon, Valencia, Spain
Hospital Clínico de Valencia
Valencia, Valencia, Spain
Hospital Dr. Peset
Valencia, Valencia, Spain
Hospital La Fe
Valencia, Valencia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SEN-AEE-2011-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.